Rheumatoid arthritis and COVID-19 outcomes: a systematic review and Meta-analysis.

ABSTRACT:

Objectives

This study aimed to conduct a comprehensive systematic literature review and meta-analysis to assess the risk and outcomes of coronavirus disease 2019 (COVID-19) in patients with rheumatoid arthritis.

Methods

A systematic search was performed across four electronic databases. The quality of the studies was assessed using the Newcastle‒Ottawa quality assessment scale and the Joanna Briggs Institute critical appraisal checklist. Statistical analyses were conducted using STATA 14 software.

Results

A total of 62 studies were included in the analysis. First, the meta-analysis revealed the following prevalence rates among rheumatoid arthritis patients: COVID-19, 11%; severe COVID-19, 18%; COVID-19-related hospitalization, 29%; admission to the intensive care unit

SUBMITTER: Jin L 

PROVIDER: S-EPMC11555839 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature